Table 5 BT detection performance of the proposed EBTS-BIFMFBO model on 70%TRPH and 30%TSPH datasets. Evaluation includes \(\:acc{u}_{y}\), \(\:pre{c}_{n}\), \(\:rec{a}_{l}\), \(\:{F1}_{score}\), and \(\:MCC\).
Classes | \(\:\varvec{A}\varvec{c}\varvec{c}{\varvec{u}}_{\varvec{y}}\) | \(\:\varvec{P}\varvec{r}\varvec{e}{\varvec{c}}_{\varvec{n}}\) | \(\:\varvec{R}\varvec{e}\varvec{c}{\varvec{a}}_{\varvec{l}}\) | \(\:{\varvec{F}1}_{\varvec{s}\varvec{c}\varvec{o}\varvec{r}\varvec{e}}\) | \(\:\varvec{M}\varvec{C}\varvec{C}\) |
|---|---|---|---|---|---|
TRPH (70%) | |||||
Meningioma | 98.20 | 95.96 | 96.15 | 96.06 | 94.89 |
Glioma | 97.60 | 97.64 | 97.26 | 97.45 | 95.18 |
Pituitary | 97.46 | 95.55 | 95.99 | 95.77 | 93.96 |
Average | 97.75 | 96.38 | 96.47 | 96.43 | 94.68 |
TSPH (30%) | |||||
Meningioma | 98.38 | 96.30 | 96.74 | 96.52 | 95.47 |
Glioma | 97.31 | 96.51 | 97.65 | 97.08 | 94.58 |
Pituitary | 97.20 | 96.45 | 94.44 | 95.44 | 93.43 |
Average | 97.63 | 96.42 | 96.28 | 96.34 | 94.49 |